How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains

Folding and Design

Volumn 3, Issue 6, 1998, Pages 513-522

  Zhou, Yingyao ^a   Abagyan, Ruben ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binding energy; Protein docking; Signal transduction; Structure prediction; Tyrosine phosphorylation

Indexed keywords

PHOSPHOTYROSINE;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; MITOGENESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0032424250     PISSN: 13590278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-0278(98)00067-4     Document Type: Article

References (70)

1. Kuriyan, J. & Cowburn, D. (1997). Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26, 259-88.
2. Pawson, T. & Schlessinger, J. (1993). SH2 and SH3 domains. Curr. Biol. 3, 434-442.
3. Cantley, L.C., et al., & Soltoff, S. (1991). Oncogenes and signal transduction. Cell 64, 281-302.
4. Margolis, B. (1996). The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling. J. Lab. Clin. Med. 128, 235-241.
5. Zhou, M.M. & Fesik, S.W. (1995). Structure and function of the phosphotyrosine binding (PTB) domain. Prog. Biophys. Mol. Biol. 64, 221-235.
6. Kavanaugh, W.M. & Williams, L.T. (1994). An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266, 1862-1865.
7. Waksman, G., et al., & Kuriyan, J. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
8. Gilmer, T., et al., & Berman, J. (1994). Peptide inhibitors of src SH3-SH2-phosphoprotein interactions, J. Biol. Chem. 269, 31711-31719.
9. Breeze, L., et al., & Cartlidge, S.A. (1996). Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85α subunit of phosphatidynositol 3-kinase. EMBO. J. 15, 3579-3589.
10. Panayotou, G., et al., & Waterfield, M.D. (1993). Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor β-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell. Biol. 13, 3567-3576.
11. Piccione, E., et al., & Shoelson, S.E. (1993). Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochem. 13, 3197-3202.
12. Narula, S.S., et al., & Dalgarno, D.C. (1995). Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine peptapeptide. Structure 3, 1061-1073.
13. lck. Nature 362, 87-91.
14. Eck, M.J., Atwell, S.K., Shoelson, S.E. & Harrison, S.C. (1994). Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature 368, 764-769.
15. src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proc. Natl Acad. Sci. USA 90, 4902-4906.
16. Sicheri, F., Moarefi, I. & Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
17. Ladbury, J.E., Lemmon, M.A., Zhou, M., Creen, J., Botfield, M.C. & Schlessinger, J. (1995). Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl Acad. Sci. USA 92, 3199-3203.
18. Felder, S., et al., & Schlessinger, J. (1993). SH2 domain exhibit high-affinity binding to tyrosine phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol. Cell Biol. 13, 1449-1455.
19. Zhou, M.M., et al., & Fesik, S.W. (1995). Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. J. Biol. Chem. 270, 31119-31123.
20. Zhou, M.M., et al., & Fesik, S.W. (1996). Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3, 388-393.
21. Zhang, Z., et al., & Kuriyan., J. (1997). Sequence-specific recognition of the interalizaiton motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16, 6141-6150.
22. Lee, C.H., et al., & Kuriyan, J. (1994). Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2, 423-438.
23. Bradshaw, J.M., Grucza, R.A., Ladbury, J.E. & Waksman, G. (1998). Probing the 'two-pronged plug two-holed socket' model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study. Biochemistry 37, 9083-9090.
24. Timms, D. & Wilkinson, A.J. (1997). Estimation of binding affinity in structure-based design. In Computer Simulation of Biomolecular Systems: Theoretical and Experimental Applications, Volume 3, (van Gunsteren, W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp. 466-493, Kluwer Academic Publishers, Boston.
25. Ajay & Murcko, M.A. (1995). Computational methods to predict binding energy in ligand-receptor complexes. J. Med. Chem. 38, 4953-4967.
26. Kollman, P.A. (1994). Theory of macromolecule-ligand interactions, Curr. Opin. Struct. Biol. 4, 240-245.
27. Lesyng, B. & McCammon, J.A. (1993). Molecular modeling methods:basic techniques and challenging problems. Pharmacol. Ther. 60:149-167.
28. Bash, P.A., Singh, U.C., Langridge, R. & Kollman, P.A. (1987). Free energy calculations by computer simulation. Science 236, 564-568.
29. Muegge, I., Schweins, T. & Warshel, A. (1998). Electrostatic contributions to protein-protein binding affinities: application to Rap/Raf interaction. Proteins 30, 407-423.
30. Vajda, S., Sippl, M. & Novotny, J. (1997). Empirical potentials and functions for protein folding and binding. Curr. Opin. Struct. Biol. 7, 222-228.
31. Rosenfeld, R., Vajda, S. & DeLisi, C. (1995). Flexible docking and design. Annu. Rev. Biophys. Biomol. Struct. 24, 677-700.
32. Horton, N. & Lewis, M. (1992). Calculation of the free energy of association for protein complexes. Protein Sci. 1, 169-181.
33. Novotny, J., Bruccoleri, R.E. & Saul, F.A. (1989). The attribution of binding energy in antigen-antibody complexes McPC 603, D1.3, HyHEL-5. Biochemistry 28, 4735-4749.
34. Novotny, J., Bruccoleri, R.E., Davis, M. & Sharp, K.A. (1997). Empirical free energy calculations: a blind test and futher improvements to the method. J. Mol. Biol. 268, 401-411.
35. Chothia, C. & Janin, J. (1975). Principles of protein-protein recognition. Science 256, 705-708.
36. Kuntz, I.D. (1992). Structure-based strategies for drug design and discovery. Science 257, 1078-1082.
37. Krystek, S., Stouch, T. & Novotny, J. (1993). Affinity and specificity of serine endopeptidase-protein inhibitor interactions: empirical free energy calculations based on X-ray crystallographic structures. J. Mol. Biol. 234, 661-679.
38. Abagyan, R.A. & Totrov, M.M. (1994). Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 235, 983-1002.
39. Lengauer. T. & Rarey, M. (1996). Computational methods for biomolecular docking. Curr. Opin. Struct. Biol. 6, 402-406.
40. Shoichet, B. & Kuntz, I.D. (1996). Predicting the structure of protein complexes: a step in the right direction. Chem. Biol. 3, 151-156.
41. Janin, J. (1995). Protein-protein recognition. Prog. Biophys. Molec. Biol. 64, 145-166.
42. Gulukota, K., Vajda, S. & DeLisi, C. (1996). Peptide docking using dynamic programming. J. Comp. Chem. 17, 418-428.
43. Abagyan, R.A. (1997). Protein structure prediction by global energy optimization. In Computer Simulation of Biomolecular Systems: Theoretical and Experimental Applications, Volume 3, (van Gunsteren, W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp.363-394, Kluwer Academic Publishers, Boston.
44. Abagyan, R.A., Totrov, M.M. & Kuznetsov, D.N. (1994). ICM - a new method for protein modeling and design. Applications to docking and structure prediction from the distorted native conformation. J. Comp. Chem. 15, 488-506.
45. Luty, B.A., Wasserman, Z.R., Stouten, P.F.W. & Hodge, D.N. (1995). A molecular mechanics/grid method for evaluation of ligand-receptor interactions. J. Comp. Chem. 16, 454-464.
46. Totrov, M.M. & Abagyan, R.A. (1997). Flexible protein-ligand docking by global energy optimization in internal coordinates. Proteins (suppl 1), 215-220.
47. lck SH2 domain in complex with two short phophotyrosyl peptides at 1.0 Å and 1.8 Å resolution. J. Mol. Biol. 256, 601-610.
48. Pascal, S.M., et al., & Forman-Kay J.D. (1994). Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide. Cell 77, 461-472.
49. Zhou, M., et al., & Fesik, S.W. (1995). Solution structure of the shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc. Natl Acad. Sci. USA 92, 7784-7788.
50. Gilson, M.K. (1997). Modeling protonation equilibria in biomolecules. In Computer Simulation of Biomolecular Systems: Theoretical and Experimental Applications, Volume 3. (van Gunsteren, W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp.199-222, Kluwer Academic Publishers, Boston.
51. Bradshaw, J. & Waksman, G. (1998). A calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high affinity tyrosyl phosphopeptide. Biochemistry 37, 15400-15407.
52. Totrov, M.M. & Abagyan, R.A. (1996). The contour-buildup algorithm to calculate the analytical molecular surface. J. Struct Biol. 116, 138-143.
53. Tunon, I., Silla, E., Pascual-Ahuir, J.L. (1992). Molecular surface area and hydrophobic effect. Protein Eng. 5, 715-716.
54. Wesson, L. & Eisenberg, D. (1992). Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Sci. 1, 227-235.
55. Rahuel, J., et al., & Grutter, M.G. (1996). Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat. Struct. Biol. 3, 586-589.
56. Zhou, M., et al., & Feslk, S.W. (1995). Structure and ligand recognition of the phosphotyrosine binding domain of shc. Nature 378, 584-592.
57. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan J. (1993). Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 770-790.
58. Totrov, M.M. & Abagyan, R.A. (1994). Detailed ab initio prediction of lysozyme-antibody complex with 1.6 Å accuracy. Nat. Struct. Biol. 1, 259-263.
59. Caflisch, A., Niederer, P. & Anliker, M. (1992). Monte Carlo docking of oligopeptides to proteins. Proteins 13, 223-230.
60. Xu, R.X., Word, J.M., Davis, D.G., Rink, M.J., Willard, D.H., Jr. & Gampe, R.T., Jr. (1995). Solution structure of the human pp60 c-src sh2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry 34, 2107-2121.
61. Pratt, W.B. Taylor, P. (1990). Principle of drug action: the basis of pharmacology, (3rd edn), Churchill Livingstone, New York.
62. Halgren, T.A. (1992). Merck Molecular Force Field. I-V. J. Comp. Chem. 17, 1995, 490-641.
63. Abagyan, R.A. & Argos, P. (1992). Optimal protocol and trajectory visualization for conformational searches of peptides and proteins. J. Mol. Biol. 225, 519-532.
64. Momany, F.A., McGuire, R.F., Burgess, A.W. & Scheraga, H.A. (1975). Energy parameters in polypeptides. VII. Geometric parameters, partial atomic charges, nonbonded interactions, hydrogen bond interactions and intrinsic torsional potentials for the naturally occurring amino acids. J. Phys. Chem. 79, 2361-2381.
65. Nemethy, G., Pottle, M.S. & Scheraga, H.A. (1983). Energy parameters in polypeptides. IX. Updating of geometric parameters, nonbonded interactions and hydrogen bond interactions for the naturally occurring amino acid. J. Phys. Chem. 87, 1883-1887.
66. Nemethy, G., et al., & Scheraga, H.A. (1992). Energy parameters in polypeptides. 10. Improved geometric parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides. J. Phys. Chem. 96, 6472-6484.
67. Strynadka, N.C.J., et al., & James, (1996). M.N.G. Molecular docking programs successfully determine the binding of a β-lactamase inhibitory protein to term-1 β-lactamase. Nat. Struct. Biol. 3, 233-239.
68. Gilson, M.K., Given, J.A. & Head, M.S. (1997). A new class of models for computing receptor-ligand binding affinities. Chem. Biol. 4, 87-92.
69. lck. Biochemistry 33, 5070-5076.
70. Case, R.D., et al., & Shoelson, S.E. (1994). SH-PTP2 SH2 domain binding specificity is defined by direct interactions with platelet-growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptide. J. Biol. Chem. 269, 10467-10474.